Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 16035945)

Published in Viral Immunol on January 01, 2005

Authors

P Meerts1, S Van Gucht, E Cox, A Vandebosch, H J Nauwynck

Author Affiliations

1: Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Belgium.

Articles citing this

Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res (2006) 1.20

Time course differential gene expression in response to porcine circovirus type 2 subclinical infection. Vet Res (2009) 0.87

Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge. BMC Vet Res (2012) 0.85

Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets. Can J Vet Res (2012) 0.80

The index herd with PMWS in Sweden: presence of serum amyloid A, circovirus 2 viral load and antibody levels in healthy and PMWS-affected pigs. Acta Vet Scand (2009) 0.80

Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs. Vet Res (2010) 0.80

Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge. Vet Res (2014) 0.80

Co-infection of porcine dendritic cells with porcine circovirus type 2a (PCV2a) and genotype II porcine reproductive and respiratory syndrome virus (PRRSV) induces CD4(+)CD25(+)FoxP3(+) T cells in vitro. Vet Microbiol (2012) 0.80

Variation in time and magnitude of immune response and viremia in experimental challenges with Porcine circovirus 2b. BMC Vet Res (2014) 0.79

Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets. PLoS One (2016) 0.78

Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic disease. Can Vet J (2016) 0.76

Porcine circovirus 2 immunology and viral evolution. Porcine Health Manag (2015) 0.75

Articles by these authors

(truncated to the top 100)

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin. Diabetes Obes Metab (2012) 2.19

A review on the morphology, molecular characterization, morphogenesis and pathogenesis of white spot syndrome virus. J Fish Dis (2008) 1.74

West Nile virus in the vertebrate world. Arch Virol (2005) 1.68

Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV). Vet Microbiol (1997) 1.63

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis (1997) 1.60

Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol (1997) 1.57

The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med (1997) 1.50

Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. J Gen Virol (2000) 1.48

Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages. J Virol (2002) 1.47

Malignant melanoma and pregnancy. Cancer (1985) 1.47

Dissemination of wild-type and gC-, gE-and gI-deleted mutants of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation. J Gen Virol (1995) 1.43

Serological prevalence study of exposure of cats and dogs in Launceston, Tasmania, Australia to spotted fever group rickettsiae. Aust Vet J (2010) 1.43

Toxic shock syndrome after a human bite to the hand. J Hand Surg Am (1988) 1.39

Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine (2004) 1.29

The complex repeats of Dictyostelium discoideum. Genome Res (2001) 1.27

Infertile or childless by choice? A multipractice survey of women aged 35 and 50. Br Med J (Clin Res Ed) (1987) 1.23

Analysis of porcine reproductive and respiratory syndrome virus attachment and internalization: distinctive roles for heparan sulphate and sialoadhesin. J Gen Virol (2005) 1.18

Identification of a putative receptor for porcine reproductive and respiratory syndrome virus on porcine alveolar macrophages. J Virol (1998) 1.12

Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection. Vet Microbiol (2007) 1.11

Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol (2002) 1.10

Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol (1998) 1.08

Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med (2001) 1.08

Low-cost intradermal rabies vaccination is indeed very promising. Clin Infect Dis (2013) 1.08

Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet (1983) 1.06

High-level expression of Chlamydia psittaci major outer membrane protein in COS cells and in skeletal muscles of turkeys. Infect Immun (1998) 1.06

Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol (1997) 1.05

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate. Cancer (1979) 1.04

IFN-alpha treatment enhances porcine Arterivirus infection of monocytes via upregulation of the porcine Arterivirus receptor sialoadhesin. J Interferon Cytokine Res (2007) 1.04

Porcine reproductive and respiratory syndrome virus infection of alveolar macrophages can be blocked by monoclonal antibodies against cell surface antigens. Adv Exp Med Biol (1998) 1.04

Replication of feline coronaviruses in peripheral blood monocytes. Arch Virol (2005) 1.03

Specific active immunotherapy for melanoma. Ann Surg (1979) 1.02

Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect Immun (1999) 1.01

Malignant melanoma in black American and white American populations. A comparative review. JAMA (1982) 0.99

Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation. Cephalalgia (2005) 0.99

Porcine circovirus 2 infection in swine foetuses inoculated at different stages of gestation. Vet Microbiol (2001) 0.99

Causal proportional hazards models and time-constant exposure in randomized clinical trials. Lifetime Data Anal (2005) 0.98

Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy. J Clin Oncol (1993) 0.96

Malignant melanoma in the elderly. J Clin Oncol (1987) 0.96

Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4/31. J Gen Virol (2005) 0.96

Immunological hiding of herpesvirus-infected cells. Arch Virol (2000) 0.96

Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge. Theriogenology (2012) 0.96

In vitro culture of porcine respiratory nasal mucosa explants for studying the interaction of porcine viruses with the respiratory tract. J Virol Methods (2007) 0.96

Isoelectric focusing of Gc (vitamin D binding globulin) in parentage testing. Hum Genet (1981) 0.96

Toxoplasma gondii and Neospora caninum in wildlife: common parasites in Belgian foxes and Cervidae? Vet Parasitol (2010) 0.95

Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies. J Gen Virol (2008) 0.95

Effect of beta-glucans on an ETEC infection in piglets. Vet Immunol Immunopathol (2008) 0.95

Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol (1999) 0.94

An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine (2007) 0.94

Long-term clinical outcome of immediate reconstruction after mastectomy. Plast Reconstr Surg (1985) 0.93

The F4 fimbrial antigen of Escherichia coli and its receptors. Vet Microbiol (2000) 0.93

Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein. Clin Exp Immunol (1999) 0.92

Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine (1999) 0.92

Different replication characteristics of historical pseudorabies virus strains in porcine respiratory nasal mucosa explants. Vet Microbiol (2008) 0.91

Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine (2004) 0.91

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia. Leukemia (2011) 0.91

Gastrointestinal transit time of nondisintegrating radio-opaque pellets in suckling and recently weaned piglets. J Control Release (2004) 0.90

Replication kinetics of neurovirulent versus non-neurovirulent equine herpesvirus type 1 strains in equine nasal mucosal explants. J Gen Virol (2010) 0.90

Quantitative changes of sialoadhesin and CD163 positive macrophages in the implantation sites and organs of porcine embryos/fetuses during gestation. Placenta (2009) 0.89

Genetic characterization of African swine fever viruses from a 2008 outbreak in Tanzania. Transbound Emerg Dis (2010) 0.89

Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype. Vet Rec (2003) 0.89

Seroprevalence of porcine circovirus types 1 and 2 in the Belgian pig population. Vet Q (2000) 0.89

Susceptibility of pig embryos to porcine circovirus type 2 infection. Theriogenology (2004) 0.89

Carbon isotopes as a tool to evaluate the origin and fate of vinyl chloride: laboratory experiments and modeling of isotope evolution. Environ Sci Technol (2002) 0.89

A homologous in vitro model to study interactions between alphaherpesviruses and trigeminal ganglion neurons. Vet Microbiol (2005) 0.89

Seroprevalence of canine herpesvirus-1 in the Belgian dog population in 2000. Reprod Domest Anim (2002) 0.89

Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine (1999) 0.88

Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain. Vaccine (2002) 0.88

Receptor-specific binding of purified F4 to isolated villi. Vet Microbiol (1999) 0.88

Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses. Vet Microbiol (2009) 0.88

Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Vet Immunol Immunopathol (2004) 0.88

Replication kinetics of different porcine circovirus 2 strains in PK-15 cells, fetal cardiomyocytes and macrophages. Arch Virol (2004) 0.87

Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1 alpha,25-dihydroxyvitamin D(3). Vaccine (2005) 0.87

Overview of recent studies of community-acquired pneumonia. Clin Infect Dis (2008) 0.87

Involvement of cellular cytoskeleton components in antibody-induced internalization of viral glycoproteins in pseudorabies virus-infected monocytes. Virology (2001) 0.87

The age-dependent expression of the F18+ E. coli receptor on porcine gut epithelial cells is positively correlated with the presence of histo-blood group antigens. Vet Microbiol (2007) 0.86

Role of the cytoplasmic tail of gE in antibody-induced redistribution of viral glycoproteins expressed on pseudorabies-virus-infected cells. Virology (1999) 0.86

Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection. Vet Immunol Immunopathol (2007) 0.86

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet Immunol Immunopathol (2002) 0.86

Immunopathological mechanisms in dogs with rupture of the cranial cruciate ligament. Vet Immunol Immunopathol (2008) 0.86

Cyclic nucleotides and cyclic nucleotide phosphodiesterase during development of Polysphondylium violaceum. Exp Cell Res (1979) 0.86

Perceived effectiveness of counselling patients about smoking among medical students in Amman, Jordan. East Mediterr Health J (2010) 0.86

Temporary disturbance of actin stress fibers in swine kidney cells during pseudorabies virus infection. Vet Microbiol (2002) 0.85

Role of anti-gB and -gD antibodies in antibody-induced endocytosis of viral and cellular cell surface glycoproteins expressed on pseudorabies virus-infected monocytes. Virology (2000) 0.85

Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows. J Vet Med B Infect Dis Vet Public Health (2006) 0.85

Porcine sialoadhesin: a newly identified xenogeneic innate immune receptor. Am J Transplant (2012) 0.85

Generation of class-selective monoclonal antibodies against the penicillin group. J Agric Food Chem (2001) 0.85

Effect of a porcine circovirus type 2 infection on embryos during early pregnancy. Theriogenology (2007) 0.85

The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate. Vaccine (2008) 0.85

Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Vet Immunol Immunopathol (2003) 0.85

Distal myopathy with focal granular degenerative change in vacuolated type 2 fibers. Clin Neuropathol (1989) 0.85

Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. J Clin Pharmacol (1999) 0.85

Inhibition of adhesion of F18+ Escherichia coli to piglet intestinal villous enterocytes by monoclonal antibody against blood group H-2 antigen. Vet Microbiol (2004) 0.84

Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit Rev Microbiol (2009) 0.84

Comparative analysis of porcine cytokine production by mRNA and protein detection. Vet Immunol Immunopathol (2001) 0.84

Differentiation of F4 receptor profiles in pigs based on their mucin 4 polymorphism, responsiveness to oral F4 immunization and in vitro binding of F4 to villi. Vet Immunol Immunopathol (2012) 0.84

The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae. Vaccine (2005) 0.83

Conserved regions in the sequence of the F4 (K88) fimbrial adhesin FaeG suggest a donor strand mechanism in F4 assembly. Vet Microbiol (2004) 0.83

Recombination of two porcine circovirus type 2 strains. Arch Virol (2009) 0.83

Porcine reproductive and respiratory syndrome virus infection is associated with an increased number of Sn-positive and CD8-positive cells in the maternal-fetal interface. Virus Res (2013) 0.83

Involvement of membrane-bound viral glycoproteins in adhesion of pseudorabies virus-infected cells. J Virol (1993) 0.82